Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 20-Nov-23 5:07 PM View:  | Dunn John Michael Director | Opexa Therapeutics, Inc. (ACER) | 17-Nov-23 | Disposition | 27,380 | -- | -- | (100%) 27.38K to 0 | |
| 20-Nov-23 5:09 PM View: | Aselage Steve Director | Opexa Therapeutics, Inc. (ACER) | 17-Nov-23 | Disposition | 483,741 | -- | -- | (100%) 483.74K to 0 | |
| 20-Nov-23 5:01 PM View: | Davis Jefferson E Chief Business Officer | Opexa Therapeutics, Inc. (ACER) | 17-Nov-23 | Disposition | 71,645 | -- | -- | (100%) 71.64K to 0 | |
| 20-Nov-23 5:05 PM View: | Joseph Donald See Remarks | Opexa Therapeutics, Inc. (ACER) | 17-Nov-23 | Disposition | 14,285 | -- | -- | (100%) 14.29K to 0 | |
| 20-Nov-23 5:03 PM View: | Palmin Harry S Chief Financial Officer | Opexa Therapeutics, Inc. (ACER) | 17-Nov-23 | Disposition | 125,000 | -- | -- | (100%) 125.0K to 0 | |
| 20-Nov-23 5:03 PM View: | Schelling Chris PRESIDENT AND CEO Director 10% Owner | Opexa Therapeutics, Inc. (ACER) | 17-Nov-23 | Disposition | 2,712,530 | -- | -- | (100%) 2.71M to 0 | |
| 01-Dec-22 4:01 PM View: | Aselage Steve Director | Opexa Therapeutics, Inc. (ACER) | 29-Nov-22 | Private Purchase | 409,836 | $1.22 | $500,000.00 | 555% 73.91K to 483.74K | |
| 01-Dec-22 4:02 PM View: | Schelling Chris President & CEO Director 10% Owner | Opexa Therapeutics, Inc. (ACER) | 29-Nov-22 | Private Purchase | 819,672 | $1.22 | $1,000,000.00 | 43% 1.89M to 2.71M | |
| 13-Dec-21 4:02 PM View: | Aselage Steve Director | Opexa Therapeutics, Inc. (ACER) | 10-Dec-21 | Market Purchase | 7,984 | $2.04 | $16,287.40 | 12% 65.92K to 73.91K | < 1% |
| 13-Dec-21 4:02 PM View: | Aselage Steve Director | Opexa Therapeutics, Inc. (ACER) | 09-Dec-21 | Market Purchase | 2,016 | $2.15 | $4,334.40 | 3% 63.91K to 65.92K | (4%) |
| 28-Jul-20 9:00 AM View: | Schelling Chris President & CEO Director 10% Owner | Opexa Therapeutics, Inc. (ACER) | 24-Jul-20 | Market Purchase | 142,857 | $3.50 | $500,000.00 | 8% 1.75M to 1.89M | (27%) |
| 28-Jul-20 9:01 AM View: | Dunn John Michael Director | Opexa Therapeutics, Inc. (ACER) | 24-Jul-20 | Market Purchase | 21,428 | $3.50 | $74,998.00 | 360% 5.95K to 27.38K | (27%) |
| 28-Jul-20 9:02 AM View: | Aselage Steve Director | Opexa Therapeutics, Inc. (ACER) | 24-Jul-20 | Market Purchase | 45,000 | $3.50 | $157,500.00 | 238% 18.91K to 63.91K | (27%) |
| 28-Jul-20 9:01 AM View: | Joseph Donald Chief Legal Officer and Secy | Opexa Therapeutics, Inc. (ACER) | 24-Jul-20 | Market Purchase | 14,285 | $3.50 | $49,997.50 | 100% 0 to 14.29K | (27%) |
| 04-Mar-20 4:25 PM View: | Andrews William T. Chief Medical Officer | Opexa Therapeutics, Inc. (ACER) | 02-Mar-20 | Payment of Exercise | 3,142 | $3.28 | $10,305.80 | (35%) 9.0K to 5.86K | 22% |
| 05-Jul-19 4:08 PM View: | Aselage Steve Director | Opexa Therapeutics, Inc. (ACER) | 03-Jul-19 | Market Purchase | 5,000 | $3.72 | $18,581.00 | 36% 13.9K to 18.91K | (31%) |
| 05-Mar-19 5:35 PM View: | Andrews William T. Chief Medical Officer | Opexa Therapeutics, Inc. (ACER) | 01-Mar-19 | Grant | 9,000 | -- | -- | 100% 0 to 9.0K | |
| 22-Aug-18 4:22 PM View: | Tvm Life Science Ventures V... Director 10% Owner | Opexa Therapeutics, Inc. (ACER) | 01-Aug-18 | Market Purchase | 275,000 | $18.00 | $4,950,000.00 | 19% 1.42M to 1.7M | (86%) |
| 18-Dec-17 4:01 PM View: | Aselage Steve Director | Opexa Therapeutics, Inc. (ACER) | 14-Dec-17 | Market Purchase | 2,000 | $12.00 | $24,000.00 | 17% 11.9K to 13.9K | (78%) |
| 12-Jan-18 2:33 PM View: | Tvm Life Science Ventures V... Director 10% Owner | Opexa Therapeutics, Inc. (ACER) | 12-Dec-17 | Market Purchase | 333,333 | $12.00 | $4,000,000.00 | 16% 2.06M to 2.4M | (78%) |
| 21-Sep-17 5:23 PM View: | Schelling Chris President and CEO Director | Opexa Therapeutics, Inc. (ACER) | 19-Sep-17 | Acquisition (other) | 1,750,000 | -- | -- | 100% 0 to 1.75M | |
| 21-Sep-17 5:25 PM View: | Dunn John Michael Director | Opexa Therapeutics, Inc. (ACER) | 19-Sep-17 | Acquisition (other) | 5,952 | -- | -- | 100% 0 to 5.95K | |
| 21-Sep-17 5:28 PM View: | Palmin Harry S Chief Financial Officer | Opexa Therapeutics, Inc. (ACER) | 19-Sep-17 | Acquisition (other) | 125,000 | -- | -- | 100% 0 to 125.0K | |
| 27-Sep-17 6:34 PM View: | Tvm Life Science Ventures V... Director 10% Owner | Opexa Therapeutics, Inc. (ACER) | 19-Sep-17 | Acquisition (other) | 2,063,980 | -- | -- | 100% 0 to 2.06M | |
| 21-Sep-17 5:28 PM View: | Aselage Steve Director | Opexa Therapeutics, Inc. (ACER) | 19-Sep-17 | Acquisition (other) | 11,905 | -- | -- | 100% 0 to 11.9K | |
| 22-Nov-16 7:31 AM View: | Barabe Timothy C Director | Opexa Therapeutics, Inc. (ACER) | 18-Nov-16 | Sale | 14,914 | $0.55 | $8,209.73 | (54%) 27.82K to 12.91K | |
| 04-Oct-16 8:01 AM View: | Richman Michael Director | Opexa Therapeutics, Inc. (ACER) | 30-Sep-16 | Grant | 6,455 | -- | -- | 33% 19.43K to 25.88K | |
| 04-Oct-16 8:02 AM View: | Seaman Scott B Director | Opexa Therapeutics, Inc. (ACER) | 30-Sep-16 | Grant | 6,455 | -- | -- | 4% 153.21K to 159.66K | |
| 04-Oct-16 8:00 AM View: | Barabe Timothy C Director | Opexa Therapeutics, Inc. (ACER) | 30-Sep-16 | Grant | 6,455 | -- | -- | 30% 21.37K to 27.82K | |
| 04-Oct-16 8:01 AM View: | Maderis Gail J Director | Opexa Therapeutics, Inc. (ACER) | 30-Sep-16 | Grant | 6,455 | -- | -- | 33% 19.43K to 25.88K | |
| 01-Jul-16 9:04 AM View: | Maderis Gail J Director | Opexa Therapeutics, Inc. (ACER) | 30-Jun-16 | Grant | 6,455 | -- | -- | 50% 12.97K to 19.43K | |
| 01-Jul-16 9:00 AM View: | Richman Michael Director | Opexa Therapeutics, Inc. (ACER) | 30-Jun-16 | Grant | 6,455 | -- | -- | 50% 12.97K to 19.43K | |
| 01-Jul-16 9:02 AM View: | Seaman Scott B Director | Opexa Therapeutics, Inc. (ACER) | 30-Jun-16 | Grant | 6,455 | -- | -- | 4% 146.75K to 153.21K | |
| 01-Jul-16 9:03 AM View: | Barabe Timothy C Director | Opexa Therapeutics, Inc. (ACER) | 30-Jun-16 | Grant | 6,455 | -- | -- | 43% 14.91K to 21.37K | |
| 18-May-16 6:31 PM View: | Maderis Gail J Director | Opexa Therapeutics, Inc. (ACER) | 16-May-16 | Grant | 6,455 | -- | -- | 99% 6.52K to 12.97K | |
| 18-May-16 9:54 PM View: | Richman Michael Director | Opexa Therapeutics, Inc. (ACER) | 16-May-16 | Grant | 6,455 | -- | -- | 99% 6.52K to 12.97K | |
| 18-May-16 6:34 PM View: | Seaman Scott B Director | Opexa Therapeutics, Inc. (ACER) | 16-May-16 | Grant | 6,455 | -- | -- | 5% 140.3K to 146.75K | |
| 18-May-16 6:30 PM View: | Barabe Timothy C Director | Opexa Therapeutics, Inc. (ACER) | 16-May-16 | Grant | 6,455 | -- | -- | 76% 8.46K to 14.91K | |
| 04-Jan-16 5:15 PM View: | Richman Michael Director | Opexa Therapeutics, Inc. (ACER) | 31-Dec-15 | Grant | 1,354 | -- | -- | 26% 5.17K to 6.52K | |
| 04-Jan-16 5:15 PM View: | Barabe Timothy C Director | Opexa Therapeutics, Inc. (ACER) | 31-Dec-15 | Grant | 1,354 | -- | -- | 19% 7.11K to 8.46K | |
| 04-Jan-16 5:17 PM View: | Maderis Gail J Director | Opexa Therapeutics, Inc. (ACER) | 31-Dec-15 | Grant | 1,354 | -- | -- | 26% 5.17K to 6.52K | |
| 02-Oct-15 8:00 AM View: | Maderis Gail J Director | Opexa Therapeutics, Inc. (ACER) | 30-Sep-15 | Grant | 1,200 | -- | -- | 30% 3.97K to 5.17K | |
| 02-Oct-15 8:00 AM View: | Richman Michael Director | Opexa Therapeutics, Inc. (ACER) | 30-Sep-15 | Grant | 1,200 | -- | -- | 30% 3.97K to 5.17K | |
| 02-Oct-15 8:00 AM View: | Barabe Timothy C Director | Opexa Therapeutics, Inc. (ACER) | 30-Sep-15 | Grant | 1,200 | -- | -- | 20% 5.91K to 7.11K | |
| 01-Jul-15 4:30 PM View: | Maderis Gail J Director | Opexa Therapeutics, Inc. (ACER) | 30-Jun-15 | Grant | 8,427 | -- | -- | 36% 23.3K to 31.73K | |
| 01-Jul-15 4:30 PM View: | Richman Michael Director | Opexa Therapeutics, Inc. (ACER) | 30-Jun-15 | Grant | 8,427 | -- | -- | 36% 23.3K to 31.73K | |
| 01-Jul-15 4:30 PM View: | Barabe Timothy C Director | Opexa Therapeutics, Inc. (ACER) | 30-Jun-15 | Grant | 8,427 | -- | -- | 22% 38.82K to 47.24K | |
| 09-Apr-15 5:21 PM View: | Maderis Gail J Director | Opexa Therapeutics, Inc. (ACER) | 08-Apr-15 | Option Exercise | 8,242 | -- | -- | 55% 15.06K to 23.3K | |
| 09-Apr-15 5:22 PM View: | Radhakrishnan Karthik Chief Financial Officer | Opexa Therapeutics, Inc. (ACER) | 08-Apr-15 | Option Exercise | 50,000 | -- | -- | 67% 74.66K to 124.66K | |
| 09-Apr-15 5:24 PM View: | Seaman Scott B Director | Opexa Therapeutics, Inc. (ACER) | 08-Apr-15 | Option Exercise | 518,707 | -- | -- | 86% 603.7K to 1.12M |
